EGF and cancer: There is crosstalk between the two pathways in EMT progression, as EGF treatment enhances IL-6 production [35], and elevated level of IL-6 is associated with cancer cell aggressiveness and metastasis by inducing EMT through activating STAT3 and Akt signaling [36].